Innocoll jumps on Phase III data for analgesic implant

Innocoll AG (NASDAQ:INNL) gained $3.40 (48%) to $10.51 after its XaraColl bupivacaine collagen

Read the full 138 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE